EPE Special Opps Ltd - Trading Statement
Announcement provided by
EPE Special Opportunities Ltd · EO.P13/02/2025 07:00

EPE Special Opportunities Limited
("ESO" or the "Company")
Trading Statement
The Board of EPE Special Opportunities is pleased to provide an update on the Company's performance for the year ended 31 January 2025.
· The Company and its portfolio have faced a challenging environment during the year ended 31 January 2025 against the backdrop of an uncertain and complex economic landscape. The Board and Investment Advisor continue to manage the Company prudently, prioritising liquidity and securing the financial position of the portfolio. Given the economic context, overall M&A activity has remained subdued and market valuations have been depressed, limiting the opportunities for new acquisitions and disposals in the period. The operational improvements and progress made against long term value creation plans within the portfolio, position our businesses for sustained growth as macro economic conditions stabilise.
· The unaudited estimate of the Net Asset Value ("NAV") per share of the Company as at 31 January 2025 was
· The share price of the Company as at 31 January 2025 was
· In January 2025, Luceco released a trading update for the year ended 31 December 2024, announcing results ahead of market expectations. The group announced sales in the region of
· Whittard of
· The Rayware Group ("Rayware") continued to face headwinds to trading performance, but has made progress on the development of its overall channel strategy in the period. In August 2024 Rayware launched a new retail channel, with its first store opened in
· Pharmacy2U ("P2U") maintained strong organic growth during the period and accelerated its underlying growth trajectory via acquisition. The integration of LloydsDirect was approved by the CMA in March 2024, delivering material additional scale to the platform and synergy opportunities. In April 2024, P2U expanded its offering to include pet care, via the acquisition of The PharmaPet Co.
· David Phillips ("DP") continues to experience profitability headwinds but enters the year with an encouraging pipeline. In July 2024, Ben Munn joined the business as CEO, with over 25 years of experience in the real estate sector. In January 2025, the Company, through its subsidiary ESO Investments 1 Limited, invested
· Denzel's achieved top line growth, expanding their offering within key retailers and securing new accounts. The business' marketing activity has been supported by new partnerships such as the collaboration with Battersea Dogs & Cats Home, launched in June 2024.
· The Company had cash balances of £11 million1 as at 31 January 2025. In July 2024, the Company agreed the extension of the maturity of
· As at 31 January 2025, the Company's unquoted portfolio was valued at a weighted average EBITDA to enterprise value multiple of 7.8x and the portfolio has a low level of third-party leverage with net debt at 1.2x EBITDA in aggregate.
Mr Clive Spears, Chairman, commented: "Due to the complex business conditions faced in the period, the priority of the Board, Investment Advisor and portfolio management teams has been to ensure the resilience of the Company and its portfolio against these headwinds. Value creation plans are in place within the portfolio to generate future growth, with close monitoring of progress maintained. Prudent action has been taken to preserve liquidity and to manage the capital structure of the Company. The Board would like to extend their thanks to the Investment Advisor and portfolio management teams for their efforts through a demanding period and look forward to updating shareholders on further progress at the half year."
The person responsible for releasing this information on behalf of the Company is Amanda Robinson of Langham Hall Fund Management (Jersey) Limited.
Note 1: Company liquidity is stated inclusive of cash held by subsidiaries in which the Company is the sole investor.
Enquiries:
EPIC Investment Partners LLP |
+44 (0) 207 269 8865 Rupert Palmer |
Langham Hall Fund Management (Jersey) Limited |
+44 (0) 15 3488 5200 Amanda Robinson |
Cardew Group Limited |
+44 (0) 207 930 0777 Richard Spiegelberg |
Deutsche Numis |
+44 (0) 207 260 1000 |
Nominated Advisor: |
Stuart Skinner |
Corporate Broker: |
Charles Farquhar |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.